Showing results (1-10 of 133) with videos related to
Sort By:
Pageof 14
Therapeutic Drug Monitoring|June 1, 1995
Analysis of desmethylmethsuximide using high-performance liquid chromatographyJ M Streete, D J Berry, L A Clarke, et al.Therapeutic Drug Monitoring|July 1, 1991
The analysis of clobazam and its metabolite desmethylclobazam by high-performance liquid chromatographyJ M Streete, D J Berry, J E NewberyTherapeutic Drug Monitoring|January 1, 1986
Phenylethylmalonamide serum levels in patients treated with primidone and the effects of other antiepileptic drugsJ M Streete, D J Berry, L I Pettit, et al.Journal of Chromatography|May 15, 1987
Gas chromatographic analysis of phenylethylmalonamide in human plasmaJ M Streete, D J BerryEuropean Journal of Clinical Pharmacology|January 1, 1987
Pharmacokinetics of phenylethylmalonamide (PEMA) in elderly menJ M Streete, D J Berry, J E Newberry, et al.Therapeutic Drug Monitoring|May 1, 1990
Clearance of phenylethylmalonamide during haemodialysis of a patient with renal failureJ M Streete, D J Berry, J A Jones, et al.Journal of Chromatography|September 11, 1978
Determination of valproic acid (dipropylacetic acid) in plasma by gas-liquid chromatographyD J Berry, L A ClarkeEpilepsia|May 13, 1998
Carbamazepine toxicity with lamotrigine: pharmacokinetic or pharmacodynamic interaction?F M Besag, D J Berry, F Pool, et al.Journal of Chromatography|April 1, 1979
Determination of sulthiame, tetrahydro-2-p-sulphamoyl-phenyl-2h-1,2-thiazine-1,1-dioxide, in plasma at therapeutic concentrations, using high-performance liquid chromatographyD J Berry, L A Clarke, G E VallinsEpilepsia|June 1, 1982
Pharmacokinetics of phenylethylmalonamide (PEMA) in normal subjects and in patients treated with antiepileptic drugsP R Cottrell, J M Streete, D J Berry, et al.Pageof 14